Your browser doesn't support javascript.
loading
No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
Lajaunie, Rébecca; Cuzin, Lise; Palich, Romain; Makinson, Alain; Bani-Sadr, Firouzé; Duvivier, Claudine; Arvieux, Cedric; Rey, David; Poizot-Martin, Isabelle; Delpierre, Cyril; Delobel, Pierre; Martin-Blondel, Guillaume.
Afiliación
  • Lajaunie R; Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France.
  • Cuzin L; Department of Infectious and Tropical Diseases, Martinique University Hospital, Fort de France, FWI and INSERM UMR 1027 Toulouse III University, Toulouse, France.
  • Palich R; Sorbonne University, Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Paris, France.
  • Makinson A; Department of Infectious and Tropical Diseases, Montpellier University Hospital, InsermU1175, Montpellier, France.
  • Bani-Sadr F; Department of Infectious and Tropical Diseases, Reims University Hospital, 45, rue Cognacq-Jay - 51092 Reims Cedex, Reims, France.
  • Duvivier C; AP-HP, Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectiology Center; IHU Imagine; Université de Paris; INSERM, U1016, Institut Cochin; CNRS, UMR8104; Institut Pasteur, Medical Center of Institut Pasteur, Necker-Pasteur Infectiology Center, Paris, France.
  • Arvieux C; Department of Infectious and Tropical Diseases, Rennes University Hospital, 2 Rue Henri le Guilloux, Rennes, France.
  • Rey D; Department of Infectious and Tropical Diseases, Strasbourg University Hospital, Strasbourg, France.
  • Poizot-Martin I; Aix Marseille University, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.
  • Delpierre C; Toulouse University, Faculté de Médecine 37 Allées Jules Guesde, Toulouse, France.
  • Delobel P; Department of Infectious and Tropical Diseases, Toulouse University Hospital and INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Toulouse, France.
  • Martin-Blondel G; Department of Infectious and Tropical Diseases, Toulouse University Hospital and INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Toulouse, France.
HIV Med ; 23(3): 301-306, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34668293
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Sarcoma de Kaposi / Infecciones por VIH / VIH-1 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: HIV Med Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Sarcoma de Kaposi / Infecciones por VIH / VIH-1 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: HIV Med Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Francia